# GLYCOPYRROLATE
> **NDA214919** · New Drug Application · Sponsor: FRESENIUS KABI USA · Approved 2022-04-21
## Drug
- **FDA Application Number:** NDA214919
- **Application type:** New Drug Application
- **Brand name:** GLYCOPYRROLATE
- **Generic name:** GLYCOPYRROLATE
- **Active ingredients:** GLYCOPYRROLATE
- **Dosage form:** SOLUTION
- **Route:** INTRAMUSCULAR, INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** FRESENIUS KABI USA
- **Manufacturer:** Fresenius Kabi USA, LLC
- **First approval:** 2022-04-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214919)
---
*AI Analytics · CC0 1.0*